Pomalidomide alone or in combination with low-dose dexamethasone in relapsed and refractory multiple myeloma: A randomized phase 2 study

Paul G. Richardson, David S. Siegel, Ravi Vij, Craig C. Hofmeister, Rachid Baz, Sundar Jagannath, Christine Chen, Sagar Lonial, Andrzej Jakubowiak, Nizar Bahlis, Kevin Song, Andrew Belch, Noopur Raje, Chaim Shustik, Suzanne Lentzsch, Martha Lacy, Joseph Mikhael, Jeffrey Matous, David Vesole, Min ChenMohamed H. Zaki, Christian Jacques, Zhinuan Yu, Kenneth C. Anderson

Research output: Contribution to journal › Article › peer-review

261 Scopus citations

Fingerprint

Dive into the research topics of 'Pomalidomide alone or in combination with low-dose dexamethasone in relapsed and refractory multiple myeloma: A randomized phase 2 study'. Together they form a unique fingerprint.

Chemical Compounds

Medicine & Life Sciences